ClinicalTrials.gg
TerminatedNCT06889207PEPPERUpdated Nov 12, 2026

Physical Exercise Prehabilitation Program in mEtabolic suRgery

An interventional study of Physical exercise prehabilitation in Obesity and Overweight, Bariatric Surgery and Prehabilitation, sponsored by Flevoziekenhuis. Terminated at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Flevoziekenhuis · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
Higher dropout rate (38% versus the 10% on which the original sample size was based). Interim analysis revealed that the effect on the primary outcome measure was already highly statistically significant.

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Mar 2022, registered Mar 2025).
Updated Nov 12, 2026Now TerminatedEnrollment updated+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 248 studies in Obesity with a site in Netherlands — 43 open to participants now, 55 under way, 14 of them phase 3. Obesity · Netherlands.

Enrollment
105th of 211
58 · median 58
Started
2022
with 11 others
No phase
128 of 248
17 open now
Registered
214th of 248
by date

Among the 248 studies in Obesity with a site in Netherlands, this one is the 105th largest by enrollment of the 211 interventional ones that give a count, is one of 12 that started in 2022, is one of 128 with no phase, and was the 214th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

43 of the 248 studies in Obesity with a site in Netherlands are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 248 studies in Obesity with a site in Netherlands, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if an exercise program before bariatric surgery works to treat obesity, could improve physical condition and weight loss before bariatric surgery and induce a lifestyle behavior change. The main questions it aims to answer are:

  • Does a supervised exercise program lead to improved physical condition prior to bariatric surgery?
  • Does a supervised exercise program prior to bariatric surgery lead to reduced surgery related complications?
  • Does a supervised exercise program prior to bariatric surgery lead to maintained lifestyle changes after surgery?

Participants will:

  • Receive either no training program or physical exercise training program twice a week, supervised by a physical therapist, for a duration of 8 weeks.
  • Have their fitness measured at the start and at the end of the 8 weeks, measured with a six minute walking test.
  • Fill in a survey on their perceived quality of life and exercise habits at the start of the trial, and at 1 year after surgery.
03

Conditions studied

  • Obesity and Overweight
  • Bariatric Surgery
  • Prehabilitation
  • Exercise
  • Physical Fitness
  • Six Minute Walk Test
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥18 years)
  • Body-Mass-Index () 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, heart and/or vascular diseases, obstructive sleep apnea (OSA), dyslipidemia, or arthritis).
  • Primary bariatric patients; without previous bariatric surgery. For inclusion the investigators will follow the National Guidelines on metabolic surgery.

Exclusion criteria

Exclusion Criteria:

Patients with:

  • mobility problems (patients who are not able to exercise)
  • cognitive disabilities
  • illiteracy (patients who are not able to read and understand the language of the country where the study will be performed)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
58 participants (actual)

Study arms

  • Active comparator
    Prehabilitation

    Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.

    Behavioral: Physical exercise prehabilitation

  • No intervention
    No prehabilitation

    Receives no exercise prehabilitation program

Interventions

  • BehavioralPhysical exercise prehabilitation

    Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.

    Also known as: Prehabilitation, Exercise program

06

What researchers measure

Primary outcomes

  1. six-minute walk test

    Preoperative physical condition, assessed by using the six-minute walk test (6MWT). The target increase of the 6MWT is 10% in the intervention group.

    Time frame: 2 months

07

Study locations

1 site
  • FlevoZiekenhuis
    Almere Stad, Flevoland 1315RA, Netherlands
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Mar 2022 to primary completion in Jun 2026, 50 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: primary completion Apr 2025 → Jun 2026 and completion May 2026 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2025
First posted
Mar 21, 2025
StartActual
Mar 14, 2022
Primary completionActual
Jun 4, 2026was Apr 2025
CompletionActual
Jun 4, 2026was May 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Terminated Higher dropout rate (38% versus the 10% on which the original sample size was based). Interim analysis revealed that the effect on the primary outcome measure was already highly statistically significant.
changed Oct 30, 2026
Sites
1 site added, 1 site removed
Show site
  • FlevoZiekenhuis · Almere Stad, Netherlands
Show 1 removed
  • FlevoZiekenhuis · Almere, Netherlands
Oct 30, 2026
Primary completion
Apr 2025→Jun 4, 2026 (actual)
Oct 30, 2026
Study completion
May 2026→Jun 4, 2026 (actual)
Oct 30, 2026
Enrollment
58 (estimated)→58
Nov 12, 2026
Show all 2 updates
  1. Nov 12, 2026
    Enrollment 48→58
    + 1 other change: verification date
  2. Oct 30, 2026
    Active, not recruiting→Terminated
    Why stopped Higher dropout rate (38% versus the 10% on which the original sample size was based). Interim analysis revealed that the effect on the primary outcome measure was already highly statistically significant.
    1 site added, 1 site removed
    Show site
    • FlevoZiekenhuis · Almere Stad, Netherlands
    Show 1 removed
    • FlevoZiekenhuis · Almere, Netherlands
    Primary completion Apr 2025→Jun 4, 2026 (now actual)
    Study completion May 2026→Jun 4, 2026 (now actual)
    Enrollment 58 (estimated)→48 (actual)
    + 4 other changes: index terms, identifiers, verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06889207
Lead sponsor
Flevoziekenhuis
Responsible party
Sponsor
First posted
Mar 21, 2025
Start date
Mar 14, 2022
Primary completion
Jun 4, 2026
Completion
Jun 4, 2026
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion